June 09, 2025

Gray and Blazed: Pot’s Risky New Demographic

As cannabis use rises among older adults, new studies reveal surprising health risks—from ER visits to potential dementia links.

KFF Health News

June 02, 2025

Kids, Interrupted: America’s Youngest Caregivers

Millions of children are caring for sick or disabled adults at home — a growing crisis fueled by shrinking Medicaid funds and fading support systems.

KFF Health News

May 30, 2025

Paging Dr. Canada: U.S. Exodus

Amid Trump’s return, more American doctors are fleeing to Canada, citing political fear, violence, and a collapsing health care climate.

KFF Health News

April 25, 2024

AHA: 2023’s Most Significant Scientific Advancements in Cardiovascular Care

The AHA provided an overview of the most notable advancements in cardiovascular disease research in 2023.

Conexiant

May 06, 2024

Stranded in the ER, Seniors Await Hospital Care and Suffer Avoidable Harm

Amid hospital bed shortages and staff limitations, older adults in emergency rooms face prolonged waits and inadequate care, presenting serious health risks.

KFF Health News

April 16, 2025

Is Primary Care Becoming Pay-to-Play?

“It’s a way to practice self-preservation in this field that is punishing patients and doctors alike” — one internist explains why some rural physicians are opting for concierge care despite the access trade-offs.

KFF Health News

May 17, 2024

Watch: John Oliver Dishes on KFF Health News’ Opioid Settlements Series

Recent reporting and analysis show how opioid settlement funds are being allocated by state and local governments in the US, shedding light on the significant restitution efforts by manufacturers, distributors, and retailers.

KFF Health News

May 30, 2023

I Was Unprepared for a Diagnosis of Mantle Cell Lymphoma

Dr. Dunn, President of the Union for International Cancer Control, shares his poignant journey from a surprising cancer diagnosis to advocating for universal health coverage.

The ASCO Post

June 11, 2024

Merck Targets Cardiometabolic Revolution with Cutting-Edge Drug Advances

Merck is pursuing next-generation cardiometabolic drug opportunities, focusing on small-molecule oral treatments with potential benefits beyond weight loss, including improvements in cardiovascular and diabetes outcomes.

Reuters